Edition:
United Kingdom

People: Omeros Corp (OMER.OQ)

OMER.OQ on NASDAQ Stock Exchange Global Market

16.92USD
17 Jun 2019
Change (% chg)

-- (--)
Prev Close
$16.92
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
157,873
52-wk High
$27.00
52-wk Low
$10.30

McCue, Justin 

Dr. Justin McCue Ph.D. is Vice President of Chemistry, Manufacturing and Controls of the company. From March 2018 to September 2018 Dr. McCue served as senior director, process development at Celgene Corporation, having joined Celgene following its acquisition of Juno Therapeutics, Inc. Dr. McCue served as Juno’s senior director, process development from September 2017 until its acquisition by Celgene in March 2018. Prior to Juno, Dr. McCue served at Biogen Inc. between 2004 to 2017, where he held positions of increasing responsibility within CMC, including roles as director of manufacturing science from January 2014 to March 2015 and director of product quality management from March 2015 to September 2016. He began his career in the biopharmaceutical division at Millipore. Dr. McCue earned his Ph.D. in chemical engineering at Massachusetts Institute of Technology after receiving a degree in chemical engineering from the University of California at Berkeley.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --